COPD @_Larix.jpg
COPD_Larix.jpg
COpd_ Larix.jpg
Date

April 23 -24, 2020

Location

Paris, France

Collaborators


Conference Overview


Welcome to the Global Meet on Copd and Respiratory Disorders Conference.We are excited to announce that Copd 2020 will be held inParis, France on April 21-22, 2020.The conference brings together Academicians, professionals, Hospitals, Industrial delegates from around the world to discuss cutting-edge research. We welcome all of you to attend the Keynotes lectures, Plenaries, Workshop, Oral presentations, Posters/Video presentation. We truly hope you will find the conference worthwhile and you will benefit from this esteemed event. Copd 2020 will be a great opportunity for everyone attending to enrich their professional network.

What to expect

  • Engage with the most experienced and influential community.
  • Learn how to use technologies to reduce time to market, produce stronger and lighter parts, improve efficiency, reduce waste and cost, and create complex geometries.
  • Consult with industry experts before you make equipment decisions.
  • Network with hundreds of attendees and see how they’re addressing challenges.
  • Experience the most respected additive conference, with over 20+ knowledgeable speakers.
  • Collaborate with users to advance applications for technologies.

IMPORTANT DATES


  • Abstract Submission opens:

    October 21, 2019


  • Abstract Submission Deadline:

    February 15, 2020


  • Standard Registration opens:

    October 21, 2019


  • Standard Registration Deadline:

    February 21, 2020

Session 01: Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms incorporate breathing trouble, cough, mucus production and wheezing. It is caused by long-term exposure to irritating gases or particulate issue, frequently from cigarette smoke. Individuals with COPD are at increased risk of creating coronary illness, lung cancer and a variety of different conditions. Emphysema and chronic bronchitis are the two most basic conditions that contribute to COPD. Chronic bronchitis is inflammation of the lining of the bronchial tubes, which convey air to and from the air sacs of the lungs. Emphysema is a condition in which the alveoli at the end of the smallest air passages of the lungs. Pulmonary Conferences provides a multidisciplinary to pulmonology researchers.

Session 02: Asthma and Allergy

Allergy occurs when the immune system in an individual responds to allergens which are substances in condition that don't cause issues for many people. This response prompts irritation (redness and swelling) that causes unfavorably susceptible conditions, which can influence different parts of the body, for example, hypersensitive rhinitis, skin inflammation or urticarial, hypersensitivity and asthma. Individuals with asthma experience a narrowing of the airway routes in the lungs, which obstructs the stream of air into and out of the lungs.

Session 03: Tuberculosis

Tuberculosis and Chronic Obstructive Pulmonary Disease carry about a significant concern in terms of morbidity and mortality around the world. This spotlight on various parts of tuberculosis as far as the association with COPD such as in the advancement of chronic airflow obstruction as a sequel of active tuberculosis and assessing the key role of cigarette smoking in the pathogenesis of both conditions. Patients determined to have tuberculosis may regularly have extensive co-morbidity such as COPD and the impact of an underlying diagnosis of COPD on results in tuberculosis is also reviewed. COPD Conferences explores the new ideas and techniques of pulmonary therapy.

Session 04: Pediatric-Pulmonary, Critical care and Sleep

A significant part of the pulmonary rehabilitation, research and pneumonic medication goes toward the youngest people from society-the new-born. For instance, the purpose behind pulmonary stenosis is a direct result of inappropriate pneumonic valve enhancement in the initial two months of fatal development. It's congenital but treatable. With a sound pulmonary stenosis diagnosis the heart valve can be replaced or repaired and children can develop normal healthy lives. Sleep apnea affects premature infants. A situation called apnea of prematurity exists when the child doesn't breath for 20 seconds or more. It is a pneumonic disease that can be treated with ventilation machines and medications. COPD Conferences explains about pediatric pulmonary, critical care and sleep which includes Pediatric emergencies, Pneumonia, Respiratory failure, Pediatric in-patient and critical care, Sepsis and Head Trauma & Concussion.

Session 05: Lung Cancer

Patients with chronic obstructive pulmonary disease are at increased risk for both the development of primary lung malignancy. Cigarette smoking is the principal hazard factor for advancement of lung disease. Passive exposure to tobacco smoke likewise can cause lung malignancy. Treatment of lung tumor can include a combination of surgery, chemotherapy, targeted therapy, immunotherapy, and radiation treatment and also newer experimental methods. Smoking suspension is the most vital measure that can keep the advancement of lung cancer. Lung Conferences concentrates on the risk factor for development of lung cancer.

Session 06: Pulmonary Hypertension

Pulmonary hypertension is a kind of hypertension that influences the supply routes in your lungs and the right side of your heart.

Session 07: Depression and anxiety in COPD

Depression and anxiety in COPD are standard in patients with chronic obstructive pulmonary disease (COPD), evaluations of their pervasiveness differ significantly. These likely reflect the variety of scales and techniques used to measure such symptoms. Patients with COPD with three or more comorbidities more likely to be frequently hospitalized and may die prematurely compared with COPD patients without comorbidities. An uplifted experience of dyspnoea is likely contributing segment to nervousness. Feelings of depression may be precipitated by the loss and grief related with the inability of COPD. Smoking has been related with nicotine addiction, and the variables that contribute to smoking may also predispose to anxiety and depressive disorders. The cause of depression and anxiety manifestations are multi factorial and include behavioral, social and biological factors. COPD Conferences paves a way towards a break-through in pulmonology research field.

Session 08: Epidemiology of COPD

Chronic obstructive pulmonary disease (COPD) is a main source of world-wide mortality and disability. On average 5– 15% of adults in industrialized nations have COPD characterized by spirometer. In 1990, COPD was determined as at the twelfth position worldwide reason for consolidated mortality and disability but it is expected to be the fifth cause by 2020 COPD has an chronic long-lasting course with irreversible decrease of forced expiratory volume in one second (FEV1), increasing nearness of dyspnoea and other respiratory manifestations, and dynamic decay of well-being status. After analysis the 10-yr survival rate is 50% with more than 33% of patients dying because of respiratory inadequacy.

Session 09: Pulmonary Rehabilitation

Pulmonary Rehabilitation is an exclusive program for education and exercise that helps to manage the breathing problems, increase the alveolar capacity for breathing, increase the energy of the individual and reduce the breathlessness. This program isolates the individual from using any of the harmful substances like tobacco, ganja or cannabis, etc. and rehabilitates them. The patients suffer a lot of pain and withdrawal symptoms. The staff assists them to exercise to bring ability to withstand and the muscle strength builds up. Breathing sessions and regular counselling sessions will also happen to make their mind and body prevent the thoughts of using the harmful substances.

Session 10: Lung Transplantation

A lung transplant expels an individual's diseased lung and replaces it with a healthy one. The healthy lung originates from a benefactor who has died. Lung transplants are utilized for individuals who are probably going to die from lung diseases within 1 to 2 years. Their conditions are severe to different medications, for example, drugs or breathing gadgets, no longer work. Lung transplants regularly are utilized to treat individuals who have serious COPD, Cystic fibrosis, Idiopathic pulmonary fibrosis, Alpha-1 antitrypsin inadequacy and pulmonary hypertension.

Session 11: Self-Management and Prevention of COPD

Self-Management and Prevention of COPD interventions assist patients with chronic obstructive pulmonary disease (COPD) acquire and practice the skills they need to carry out disease particular medical regimens, guide changes in health behavior and provide passionate help to empower patients to control their ailment. Patients with COPD affirmed by spirometer and symptoms and airflow obstruction should be monitored frequently to guide modification of treatment and to distinguish complications early. Pulmonary Conferences will be focused around the self-management support programmes should be collaborative between healthcare professionals and patients, to enable them to secure abilities to understand and manage with their medications and exacerbation of COPD, embrace healthier behaviors and deal with the social-emotional consequences of the disease.

Session 12: Antitrypsin Deficiency & Pulmonary Disease

Alpha-1 antitrypsin deficiency is a genetic disorder that is passed on in families and affects the lungs, liver and skin. When this condition affects the lungs, it causes COPD. There is no cure, but treatment can help people with Alpha-1 antitrypsin deficiency manage their symptoms and live a better life. The earliest symptoms are shortness of breath following mild activity, reduced ability to exercise, and wheezing. Other signs and symptoms include unintentional weight loss, recurring respiratory infections, fatigue, and rapid heartbeat upon standing. Affected individuals often develop emphysema, which is a lung disease caused by damage to the small air sacs in the lungs. Alpha-1 antitrypsin deficiency accounts for 1 to 2% of all cases of chronic obstructive pulmonary disease.

Session 13: Cardiopulmonary disease

Cardiopulmonary disease is the medical term used to describe a range of serious disorders that affect the heart and lungs. The two-primary tobacco-related cardiopulmonary diseases are Cardiovascular Disease (CVD) and Chronic Obstructive Pulmonary Disorder (COPD). Early identification and treatment of cardiopulmonary disease is crucial for reversing organ damage and preventing further injury to the organs. E-cigarettes produce ultra-fine particulate matter and cytotoxic chemicals, which are known to negatively impact heart and lung function, respectively. Nicotine itself is known to impair lung function, particularly in adolescents.

Session 14: Respiratory Diseases

Respiratory disorder is a term that encompasses a variety of pathogenic conditions that affect respiration in living organisms. Respiration involves gas exchange in higher organisms. Respiratory disorders occur in the respiratory tract, which includes the alveoli, bronchi, bronchi oles, pleura, pleural cavity, trachea and the nerves and muscles of breathing. Respiratory disorders or lung diseases include COPD, asthma, cystic fibrosis, emphysema, lung cancer, interstitial lung disease, mesothelioma, pulmonary hypertension, tuberculosis, alpha-1 antitrypsin deficiency, bronchiectasis, idiopathic pulmonary fibrosis, pneumonia, respiratory failure, respiratory distress syndrome, sarcoidosis, sleep apnea, sleep deprivation and deficiency, influenza and many more. If left untreated, lung disease can produce health complications and life-threatening conditions.

Session 15: Respiratory Tract Infections

Respiratory tract generally polluted of the Sinuses, throat and avionics courses or Lungs. They are all things considered realized by disease or organisms, generally people visit their general specialists and medication master in light of ordinary infection is the most spread of RTI. All things considered social protection specialists keep up partition between Upper Respiratory Tract Infections which is sway through nose and sinus, throat and another is lower Respiratory Tract Infections which is sway from flying course and Lungs. RTI generally influencing in adolescents' than experienced childhood considering the way that they haven't more noteworthy immunity resistance and various contamination can cause these Pulmonary infections. At whatever point your Sneeze or hack if these someone else breathed in they become polluted. Despite whether anyone contact your surface or any articles the contamination may experience someone else to avoid these sort of Lung illnesses you have to reliably clean your hands with chemical or warm water.

Sleep apnoea:

Sleep apnea is a serious sleep disorder that occurs when a person's breathing is interrupted during sleep. People with untreated sleep apnea stop breathing repeatedly during their sleep, sometimes hundreds of times. This means the brain -- and the rest of the body -- may not get enough oxygen. Sleep apnea can affect anyone at any age, even children

There are two types of sleep apnea:

Obstructive sleep apnea (OSA): The more common of the two forms of apnea, it is caused by a blockage of the airway, usually when the soft tissue in the back of the throat collapses during sleep.

Central sleep apnea: Unlike OSA, the airway is not blocked, but the brain fails to signal the muscles to breathe, due to instability in the respiratory control center.

Complex sleep apnea syndrome, also known as treatment-emergent central sleep apnea, which occurs when someone has both obstructive sleep apnea and central sleep apnea

Advanced Respiratory Disease Treatment:

 

Respiratory disease causes an immense worldwide health burden. Most bacterial respiratory infections are treatable with antibiotics and most viral infections are self-limited. Yet millions of people die of pneumonia. The failure to prevent these deaths largely results from lack of access to healthcare or the inability of the healthcare system to care for these individuals. The most effective way to manage these diseases is through standard case management. Case management is defined as “a collaborative process of assessment, planning, facilitation, care coordination, evaluation, and advocacy for options and services to meet an individual’s and family’s comprehensive health needs through communication and available resources to promote quality cost-effective outcomes”. For childhood pneumonia, this involves a standard approach to diagnosis and treatment, as has been developed by the Who in the Integrated Management of Childhood Illness programme. The contribution of case management is well illustrated in the Child Lung Health services developed in Malawi, in collaboration with The Union. In this resource-limited country, adopting a standardized case management programme, training health workers and developing the infrastructure to implement the programme steadily improved the outcome for children under 5 years of age with pneumonia. The cornerstone of pneumonia management is appropriate diagnosis and use of antibiotics.

Cystic fibrosis and Genetic Disorders:

 

Cystic fibrosis (CF) is a genetic disorder that causes mucus to build up and damage organs in the body, particularly the lungs and pancreas. Signs and symptoms may include salty-tasting skin; persistent coughing; frequent lung infections; wheezing or shortness of breath; poor growth; weight loss; greasy, bulky stools; difficulty with bowel movements; and in males, infertility. Over time, mucus build-up and infections can lead to permanent lung damage, including the formation of scar tissue (fibrosis) and cysts in the lungs. CF is caused by mutations in the CFTR gene and inheritance is autosomal recessive. Treatment aims to relieve symptoms and usually includes respiratory therapies, inhaled medicines, pancreatic enzyme supplement, and nutritional supplements. Newer medications such as CFTR modulators have been approved for use in the United States. Ongoing research is focused on finding a cure for the disease.

Attendee Criteria

Attendees would be active researchers, industrialists, scientists, associations, societies, PhD and post doc fellows, students, faculty, Subject experts and Entrepreneurs. Authors of accepted abstracts are pre-approved for registration. All other researchers must Sign up and register towards the conference.

A very limited number of spots are available for individuals in Keynote/Plenary positions.  Some of the Keynote and Plenary Speakers will have an opportunity to chair any session during the conference.

25 Oral presentation spots are available for 2-day events. The individual speaker is allowed to present a maximum of 2 talks at the conference.

 

Who Can Attend

Researcher/Academic /Industrial / Clinical / Private / Marketing

Researchers actively participating in basic science investigations, clinical studies, or epidemiologic research.

 

Physicians & Scientists who have faculty appointments at academic institutions including medical school programs, or practitioners who are involved in patient care or counselling.

 

Industries related to pharmaceuticals, Manufacturing, Services, Clinical can achieve visibility and credibility, exhibiting at a trade show has hundreds of benefits for your business. Establishing a presence, whether big or small, for your company at an exhibition gives you a powerful platform for meeting new customers, reaching out to your existing clients, and building a more established and reliable brand.

 

Clinical takes advantage of the educational and networking opportunities designed for hospital professional.

 

Marketers from generating new business to staying current with the latest trends, attending marketing events, meetings, and conferences can be crucial to the success of a company’s or individual’s growth strategy. There are some key benefits for why marketers should consider attending networking events.

 

1. Build Meaningful Relationships

2. Stay Current with Trends by Learning from Powerful Speakers

3. Connect with Influencers and in Turn, You’re Target Audience

4. Get Fresh Ideas and Solutions for Your Business.

 

Various sessions in our Conferences:

Plenary Talk: A plenary talk of a conference which all members of all parties are to attend. Such a session may include a broad range of content, from keynotes to panel discussions, and is not necessarily related to a specific style of presentation or deliberative process.





Keynote: This is a talk on a specific theme which represent the whole subject of the conference. Keynotes are usually delivered by Professors, President of associations, MD and above.



Oral Presentation: A presentation is a process of presenting a topic to an audience. It is typically a demonstration, introduction, lecture, or speech meant to inform, persuade, inspire, motivate, or to build goodwill or to present a new idea or product.



Delegate: One who gains knowledge, comprehension or mastery through experience or study; someone who learns or takes knowledge or beliefs; one that is learning; one that is acquiring new knowledge, behaviour’s, skills, values or preferences.



Poster Presentation: A poster presentation, at a congress or conference with an academic or professional focus, is the presentation of research information, usually peer-reviewed work, in the form of a poster that conference participants may view. A poster session is an event at which many such posters are presented.



Workshop: A workshop is designed to teach something or develop a specific skill while an academic conference is about presenting original research and getting feedback from peers. A workshop doesn't necessarily have to present original research; it is directed more towards teaching and learning in an interactive environment.



E-poster: An e-Poster or digital poster is a digital presentation of research that is presented within a congress.



Video Presentation: Animated or recorded video describing a research or review topic. Video talks for usually not more than 20-30mins)

Our Speakers


Larix Conferences 2020 - the day is designed to make it happen!.
Witness some of the great leaders, bright minds leading the industrial revolution and business innovators sharing insights on embracing the future and advancing their knowledge with scientific solutions.
Inspiring keynote presentations

Testimonials


Venue & Updates


paris_Larix.png

Paris, France


Paris, city and capital of France, situated in the north-central part of the country. The city is ringed with great forests of beech and oak; they are called the “lungs of Paris,” for they help to pur... Read More
Coming_soon_larix.jpg

Venue


. Read More
lungs_Larix.jpg

Recent Updates


Primary and Latest Updates in Copd and Respiratory disorders  Read More

Attended by Industry Leaders


Media Partners


K C_Larix.jpg
worlds_Larix.png
Facebook
Pinterest
Twitter
LinkedIn
blog Blog
Youtube